Bill Gates says investment in innovation is the important part of ESG

Bill Gates says investment in innovation is the important part of ESG


Microsoft co-founder Bill Gates on Tuesday addressed the issue of businesses that exaggerate environmental, social and governance credentials, arguing that though corporate sustainability credentials are often controversial, they are still critical for assessing whether to invest in a company.

“The part that I believe in is where you accelerate the innovation. To me, it’s not so much who you don’t invest in but who you do invest in,” Gates said during an interview with CNBC’s Diana Olick.

The comments come after the Securities and Exchange Commission earlier this year proposed new rules that would prevent misleading or deceptive claims by U.S. funds on their ESG qualifications and increase disclosure requirements for those funds.

Gates, who is also the founder of Breakthrough Energy Ventures, a leading climate technology investment company, said there is a modest number of companies that will drive down the cost of choosing clean technology over alternatives that emit more planet-warming greenhouse gases.

“I give people strong points where they’re making those investments and becoming customers of those green technologies,” Gates said. “The ‘E’ part — lot of controversy, but there is a way to measure it, and it should be one of the factors people look at when they invest in companies.”

Global ESG funds received a record $649 billion in investments in 2021 through Nov. 30, up from $542 billion in 2020 and $285 billion in 2019, according to financial services firm Refinitiv Lipper. Definitions of ESG often vary and difficult to measure, creating issues for businesses looking to boast their sustainability credentials to investors.

  • “The whole measurement thing is a little immature,” Gates said of ESG criteria. “The field is going to get mature on that. But having that environmental incentive — a lot of investors really do want to get that information.”



Source

More than 20,000 people are taking Eli Lilly’s weight loss pill Foundayo, CEO says
Business

More than 20,000 people are taking Eli Lilly’s weight loss pill Foundayo, CEO says

More than 20,000 people have started taking Eli Lilly‘s GLP-1 pill Foundayo in its first few weeks on the market, Lilly CEO Dave Ricks told CNBC on Thursday. The FDA approved Lilly’s once-daily pill Foundayo earlier this month, making it the second oral GLP-1 drug behind Novo Nordisk’s Wegovy pill. Investors have been closely tracking […]

Read More
Lawyers to the wealthy warn that AI legal advice comes with serious risks
Business

Lawyers to the wealthy warn that AI legal advice comes with serious risks

Displeased couple having problems during a meeting with their agent in the office. Skynesher | E+ | Getty Images A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. Lawyer Tasha Dickinson said […]

Read More
Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket
Business

Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket

David Ricks, chief executive officer of Eli Lilly & Co., at the Semafor World Economy Summit during the International Monetary Fund (IMF) and World Bank Spring meetings in Washington, DC, US, on Friday, April 17, 2026. Aaron Schwartz | Bloomberg | Getty Images Eli Lilly on Thursday reported first-quarter earnings and revenue that blew past […]

Read More